Stifel Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $72
A Quick Look at Today's Ratings for ConMed(CNMD.US), With a Forecast Between $72 to $97
A Quick Look at Today's Ratings for ConMed(CNMD.US), With a Forecast Between $74 to $97
Conmed Analyst Ratings
Wells Fargo Maintains ConMed(CNMD.US) With Hold Rating, Announces Target Price $71
Wells Fargo Remains a Hold on Conmed (CNMD)
Conmed Price Target Maintained With a $97.00/Share by Needham
Conmed Analyst Ratings
Needham Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $97
Analysts Have Conflicting Sentiments on These Healthcare Companies: Trevi Therapeutics (TRVI), Conmed (CNMD) and Revance Therapeutics (RVNC)
Wells Fargo Maintains ConMed(CNMD.US) With Hold Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Conmed (CNMD) and Ironwood Pharma (IRWD)
Conmed (CNMD) Gets a Hold From Wells Fargo
Conmed Performance Analysis: Hold Rating Justified Amid Supply Chain Resolutions and Gross Margin Adjustments
Piper Sandler Maintains Overweight on Conmed, Lowers Price Target to $80
Stifel Nicolaus Sticks to Their Buy Rating for Conmed (CNMD)
Stifel Maintains ConMed(CNMD.US) With Buy Rating, Cuts Target Price to $76
Wells Fargo Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $71
Conmed Price Target Cut to $97.00/Share From $106.00 by Needham
Conmed Analyst Ratings